Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Example of Drug Shortage Information and Links
National Resources:
FDA Drug Shortages & Discontinuations
Rpharmy Memorial Drug Shortage Information: (updated June 19, 2026)
| Drug Products on Critical Shortage | |
| Drug Name | Details |
| buprenorphine injectable | Supply is critical Est. release: Dec 2026 |
| epoprostenol Glycine (Flolan®) | Supply is critical. Est. release: periodic and in small quantities |
| hydroxycobalamin injectable | Supply is critical Est. release: none. Sodium thiosulfate is also unavailable to purchase |
| ifosfamide injectable | Supply is depleted. Est. release: Sep 2026 |
| penicillin G benzathine injectable | Supply is critical. Est. release: 1.2MU and 2.4MU: Nov 2026; 0.6MU: Nov 2027. |
| Drug Products on Shortage - Limited Availability | |
| Drug Name | Details |
| fentanyl patches | Supply of 25mcg, 75mcg, and 100mcg patches is limited at. Est. release: periodic and unpredictable. (12mcg and 50mcg patches are available) |
| iodinated contrast (Omnipaque®, Visipaque®) | Supply of most strengths/sizes are limited. Est. release unpredictable |
| lidocaine 4% topical/mucosal solution | Supply is limited. Est. release: none |
| methohexital 500 mg injection | Supply is limited. Est. release: Oct 2026 |
| midazolam 2 mL pres-free injectable | Supply is limited. Est. release: Dec 2026 |
| thrombin 5,000 units | Supply is limited. Est. release: Sep 2026 |
| trastuzumab-dkst (Ogivri®) | Supply is limited. Est. release: none |
| Relevant Products on National Shortage – No Practice Changes Needed | |
| Drug Name | Details |
| carboplatin injectable | Supply is adequate to meet needs. |
| eravacycline 50 mg vial | Supply is adequate to meet needs. |
| sodium thiosulfate injectable | Supply is adequate to meet needs. |
| Discontinued (no longer being manufactured) | |
| Drug Name | Notes/Information |
| chlorothiazide oral | Diuril oral suspension, Bausch Health, 250 mg / 5 mL 237 mL bottle, NDC 65649-0311-12 - discontinued. There are no products available. |
| dextrose-lidocaine 7.5%-5% 2mL | Pfizer discontinued 5% lidocaine and 7.5% dextrose 2 mL ampules. Pfizer is the sole supplier of this combination. |
| lindane products | All presentations have been discontinued FDA Orange Book |
| testosterone transdermal patches | All presentations have been discontinued FDA Orange Book |